CC
OPTR

Carlson Capital’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Carlson Capital’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,177,400
Closed -$14.8M – 361
2013
Q3 		$14.8M Buy
+1,177,400
New +$15.6M 0.2% 174

Carlson Capital's OPTR Position: Q4 2013 in Review

Carlson Capital sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,177,400 shares — an estimated $14.8M sold.

Carlson Capital first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $14.8M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Carlson Capital reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Carlson Capital sold 1,177,400 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $14.8M.
  • Carlson Capital first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Carlson Capital's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $14.8M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Carlson Capital's 13F filing for Q4 2013, filed 14 Feb 2014.